Many North Americans, no matter how accepting they are of biotechnology in crops, are more queasy when it comes to tinkering ...
Lakshita Bhagtani transitioned from biotechnology to management studies at the University of Exeter, navigating the ...
Funding backs a human-first approach to drug safety and efficacy, reducing reliance on animal testing and accelerating therapies for patients. NEW HAVEN, CT / ACCESS Newswire / December 5, 2025 / ...
Findings set the stage for further investigation of hSFRP2 mAb as a targeted therapy for triple-negative breast cancer.
Complete response (CR) observed in 70% (35/50) of patients with low-grade upper tract urothelial cancer (UTUC) who completed ...
Teva Pharmaceutical Industries has announced the findings from the final analysis of the real-world pan-European PEARL Phase ...
In a remarkable stride towards environmental sustainability, researchers at the Department of Biotechnology and Medical ...
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...
Scientists have found that common foods can contain hidden contaminants formed during cooking or through environmental ...
New analyses from the ongoing open label extension (OLE) studies and findings from electroencephalogram (EEG) assessments in ...
New research led by scientists at the American Museum of Natural History and the Smithsonian's National Museum of Natural History reveals that the majority of dogs living today have low but detectable ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. MAIA Biotechnology, Inc. has announced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results